Search
for
Sort by
Research 31–60 of 1000+
- A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men
- Androgenetic Alopecia in Women
- Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia
- Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
- Androgenetic alopecia and microinflammation
- Finasteride increases anagen hair in men with androgenetic alopecia
- Prevalence of androgenetic alopecia in China: a community-based study in six cities
- Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss
- Early androgenetic alopecia as a marker of insulin resistance
- Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment
- Psychological Effect, Pathophysiology, and Management of Androgenetic Alopecia in Men
- Androgenetic Alopecia: An Update of Treatment Options
- Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
- Platelet-Rich Plasma for Androgenetic Alopecia
- Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device–Controlled Multicenter Trial
- Androgenetic Alopecia
- PHOTOGRAPHIC DOCUMENTATION OF HAIR GROWTH IN ANDROGENETIC ALOPECIA
- Quality of Life Assessment in Male Patients with Androgenetic Alopecia: Result of a Prospective, Multicenter Study
- A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women
- A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia
- Hair follicle stem cell differentiation is inhibited through cross‐talk between Wnt/β‐catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia
- Histological features of peripilar signs associated with androgenetic alopecia
- Oxidative Stress–Associated Senescence in Dermal Papilla Cells of Men with Androgenetic Alopecia
- Association of Androgenetic Alopecia With Smoking and Its Prevalence Among Asian Men
- The midline part: An important physical clue to the clinical diagnosis of androgenetic alopecia in women
- Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia)
- Androgenetic alopecia: An update
- Depression Circumstantially Related to the Administration of Finasteride for Androgenetic Alopecia